Literature DB >> 30556488

Long-Term Cognitive Effects of Kratom (Mitragyna speciosa Korth.) Use.

Darshan Singh1, Suresh Narayanan2, Christian P Müller3, Balasingam Vicknasingam1, Murat Yücel4, Eric Tatt Wei Ho5, Zurina Hassan1, Sharif Mahsufi Mansor1.   

Abstract

Kratom or Mitragyna speciosa (Korth.) is a medicinal plant of Southeast Asia. As a result of its opioid-like effects, it remains unknown whether consumption of kratom tea is associated with impaired cognitive function. We assessed the cognitive function of 70 regular kratom users and 25 control participants using the Cambridge Neuropsychological Test Automated Battery. Participants performed six neuropsychological tasks that assessed motor, learning and memory, attention and executive function. Relative to control participants, higher consumption (>3 glasses daily or mitragynine doses between 72.5 mg and 74.9 mg) of kratom tea was selectively associated with impaired performance on the Paired Associates Learning task, reflecting deficits in visual episodic memory and new learning. Overall, the performance of kratom users compared to control participants, and the performance of high (>3 glasses per day) as well as low (≤3 glasses per day) kratom using groups, were comparable on all neuropsychological domains. Higher intake of kratom juice (>3 glasses daily) did not appear to impair motor, memory, attention or executive function of regular kratom users.

Entities:  

Keywords:  CANTAB; Kratom; Paired Associates Learning; memory; mitragynine

Mesh:

Substances:

Year:  2018        PMID: 30556488     DOI: 10.1080/02791072.2018.1555345

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  8 in total

1.  Kratom Use Among U.S. Adolescents: Analyses of the 2019 National Survey on Drug Use and Health.

Authors:  Vinita Sharma; Linda B Cottler; Cristina B Bares; Catalina Lopez-Quintero
Journal:  J Adolesc Health       Date:  2021-11-23       Impact factor: 7.830

2.  Self-reported Health Diagnoses and Demographic Correlates With Kratom Use: Results From an Online Survey.

Authors:  Rhiannon Bath; Tanner Bucholz; Amy F Buros; Darshan Singh; Kirsten E Smith; Charles A Veltri; Oliver Grundmann
Journal:  J Addict Med       Date:  2020 May/Jun       Impact factor: 4.647

3.  Mitragynine Attenuates Morphine Withdrawal Effects in Rats-A Comparison With Methadone and Buprenorphine.

Authors:  Rahimah Hassan; Cheah Pike See; Sasidharan Sreenivasan; Sharif M Mansor; Christian P Müller; Zurina Hassan
Journal:  Front Psychiatry       Date:  2020-05-07       Impact factor: 4.157

4.  Kratom instrumentalization for severe pain self-treatment resulting in addiction - A case report of acute and chronic subjective effects.

Authors:  Elisabeth Müller; Thomas Hillemacher; Christian P Müller
Journal:  Heliyon       Date:  2020-07-21

Review 5.  Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples.

Authors:  Vânia Meireles; Tiago Rosado; Mário Barroso; Sofia Soares; Joana Gonçalves; Ângelo Luís; Débora Caramelo; Ana Y Simão; Nicolás Fernández; Ana Paula Duarte; Eugenia Gallardo
Journal:  Medicines (Basel)       Date:  2019-03-04

Review 6.  Kratom Abuse Potential 2021: An Updated Eight Factor Analysis.

Authors:  Jack E Henningfield; Daniel W Wang; Marilyn A Huestis
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

7.  Kratom use for depression/anxiety self-management: challenges during the COVID-19 pandemic - A case report.

Authors:  Elisabeth Müller; Thomas Hillemacher; Christian P Müller
Journal:  Heliyon       Date:  2021-05-10

Review 8.  A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans.

Authors:  Elisabeth Prevete; Kim Paula Colette Kuypers; Eef Lien Theunissen; Ornella Corazza; Giuseppe Bersani; Johannes Gerardus Ramaekers
Journal:  Hum Psychopharmacol       Date:  2021-07-26       Impact factor: 2.130

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.